12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | March 09, 2023 01:31pm

Gainers

• Neoleukin Therapeutics (NASDAQ:NLTX) stock moved upwards by 33.3% to $0.71 during Thursday's regular session. Neoleukin Therapeutics's stock is trading at a volume of 9.5 million shares as of 12:30 EST. This is 3821.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $30.1 million.
• Biophytis (NASDAQ:BPTS) shares increased by 32.0% to $0.66. As of 12:30 EST, Biophytis's stock is trading at a volume of 2.3 million, which is 304.8% of its average full-day volume over the last 100 days. The company's market cap stands at $13.4 million.
• Avenue Therapeutics (NASDAQ:ATXI) stock increased by 24.02% to $1.29. Avenue Therapeutics's stock is trading at a volume of 5.6 million shares as of 12:30 EST. This is 626.8% of its average full-day volume over the last 100 days. The company's market cap stands at $7.1 million.
• Assertio Holdings (NASDAQ:ASRT) shares increased by 17.28% to $6.99. Assertio Holdings's stock is trading at a volume of 3.7 million shares as of 12:30 EST. This is 229.4% of its average full-day volume over the last 100 days. The company's market cap stands at $337.5 million. As per the news, the Q4 earnings report came out yesterday.
• OpGen (NASDAQ:OPGN) stock moved upwards by 17.24% to $1.16. Trading volume for OpGen's stock is 1.2 million as of 12:30 EST. This is 242.8% of its average full-day volume over the last 100 days. The company's market cap stands at $3.7 million.
• Macrogenics (NASDAQ:MGNX) stock increased by 15.63% to $6.36. Trading volume for Macrogenics's stock is 599.3K as of 12:30 EST. This is 96.0% of its average full-day volume over the last 100 days. The company's market cap stands at $390.9 million.

Losers

• InVivo Therapeutics Hldg (NASDAQ:NVIV) stock declined by 46.0% to $1.15 during Thursday's regular session. The current volume of 1.4 million shares is 2167.7% of InVivo Therapeutics Hldg's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $3.2 million.
• Akebia Therapeutics (NASDAQ:AKBA) stock fell 22.82% to $0.8. As of 12:30 EST, this security is trading at a volume of 5.4 million shares, making up 226.4% of its average full-day volume over the last 100 days. The company's market cap stands at $146.4 million. The company's, Q4 earnings came out today.
• Fulcrum Therapeutics (NASDAQ:FULC) stock declined by 19.65% to $5.03. As of 12:30 EST, this security is trading at a volume of 1.9 million shares, making up 173.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $310.1 million. The company's, Q4 earnings came out today.
• iBio (AMEX:IBIO) shares decreased by 16.37% to $1.64. Trading volume for this security as of 12:30 EST is 943.6K, which is 28.0% of its average full-day volume over the last 100 days. The company's market cap stands at $20.2 million.
• Predictive Oncology (NASDAQ:POAI) stock declined by 15.79% to $0.35. Trading volume for Predictive Oncology's stock is 1.1 million as of 12:30 EST. This is 295.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $27.1 million.
• OptimizeRx (NASDAQ:OPRX) shares decreased by 14.97% to $13.81. As of 12:30 EST, OptimizeRx's stock is trading at a volume of 558.1K, which is 336.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $236.8 million. As per the news, the Q4 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKBA ASRT ATXI BPTS FULC IBIO MGNX NLTX NVIV OPGN OPRX POAI